Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Dhanvantri Jeevan Rekha Ltd
Your Vote -
Buy
20.00%
Hold
40.00%
Sell
40.00%
20.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Dhanvantri Jeevan Rekha Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Dhanvantri Jeeva Q3 net profit up 13.33% at Rs 0.17 cr
-
Dhanvantri Jeeva - Result Forquater Dec 2025
-
Dhanvantri Jeeva - Board Meeting Outcome for Quartely Results For The Quater Ending Dec 2025
-
Dhanvantri Jeeva - Board Meeting Intimation for Board Meeting For Financial Result 12-02-2026
-
Dhanvantri Jeeva has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
Dhanvantri Jeeva - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Dhanvantri Jeevan Rekha Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 10.131 | 9.4737 | 9.3085 | 9.5251 | 9.1061 |
| Liabilities | 10.131 | 9.4737 | 9.3085 | 9.5251 | 9.1061 |
| Equity | 4.1536 | 4.1536 | 4.1536 | 4.1536 | 4.1536 |
| Gross Profit | 0.7188 | 0.8339 | 0.58 | 1.4921 | -0.7492 |
| Net Profit | 0.5061 | 0.1652 | -0.2166 | 0.4901 | -1.4233 |
| Cash From Operating Activities | -0.2892 | 2.5162 | -39.02 | 0.001 | -0.3488 |
| NPM(%) | 2.23 | 0.8 | -1.22 | 2.92 | -14.55 |
| Revenue | 22.6502 | 20.4619 | 17.6848 | 16.7715 | 9.7823 |
| Expenses | 21.9314 | 19.628 | 17.1048 | 15.2793 | 10.5315 |
| ROE(%) | 5.06 | 1.65 | -2.16 | 4.9 | -14.23 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Dhanvantri Jeevan Rekha Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 731.00 | 0.32 | 43.09 | 14.76 | 301.39 | 0.69 |
| Lotus Eye Hospital and Institute Ltd | 117.30 | -4.98 | 379.06 | 53.78 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 18.22 | -2.57 | 0.00 | 111.66 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 635.80 | -0.87 | 0.00 | 50.72 | -604.77 | 0.00 |
Company Info
The Company was incorporated on 11th day of June, 1993 as a Public Limited Company with the Registrar of Companies in Utter Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). The company obtained certificate for commencement of business on 2nd August 1993. The Company was incorporated with an authorised capital of Rs. 200.00 lacs which was subsequentiy increased to Rs. 500.00 Lacs from time to time. In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagonostic equipments in the Urology and Cardiology sections have already been installed and are in operation. The first case of Therapeutic services un urology section has been successfully performed on 10/ 01/95. 2002 -The Company appointed Mr Virendra Singh Phull as Managing Director. 2008 -The Company has recommend dividend of 4% on the equity. 2011 -The Company has recommended final dividend of 4% (equivalent to Rs. 0.40) per Equity share (face value Rs. 10/- each ).
The Company was incorporated on 11th day of June, 1993 as a Public Limited Company with the Registrar of Companies in Utter Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). The company obtained certificate for commencement of business on 2nd August 1993. The Company was incorporated with an authorised capital of Rs. 200.00 lacs which was subsequentiy increased to Rs. 500.00 Lacs from time to time. In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagonostic equipments in the Urology and Cardiology sections have already been installed and are in operation. The first case of Therapeutic services un urology section has been successfully performed on 10/ 01/95. 2002 -The Company appointed Mr Virendra Singh Phull as Managing Director. 2008 -The Company has recommend dividend of 4% on the equity. 2011 -The Company has recommended final dividend of 4% (equivalent to Rs. 0.40) per Equity share (face value Rs. 10/- each ).
Read More
Parent Organisation
Dhanvantri Jeevan Rekha Ltd.
Founded
11/06/1993
Managing Director
Mrs.Shalini Sharma
NSE Symbol
FAQ
The current price of Dhanvantri Jeevan Rekha Ltd is
The 52-week high for Dhanvantri Jeevan Rekha Ltd is
The market capitalization of Dhanvantri Jeevan Rekha Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Dhanvantri Jeevan Rekha Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Dhanvantri Jeevan Rekha Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dhanvantri Jeevan Rekha Ltd shares.
The CEO of Dhanvantri Jeevan Rekha Ltd is Mrs.Shalini Sharma, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
